Efficacy of Escitalopram in the Treatment of Internet Addiction
NCT00565422 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 31
Last updated 2008-05-28
Summary
The purpose of this study was to determine whether Lexapro (Escitalopram) is safe and effective in treating problematic internet use.
Conditions
- Internet Addiction
Interventions
- DRUG
-
Escitalopram
10 mg/day
Sponsors & Collaborators
-
Forest Laboratories
collaborator INDUSTRY -
Icahn School of Medicine at Mount Sinai
lead OTHER
Principal Investigators
-
Eric Hollander, MD · Icahn School of Medicine at Mount Sinai
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-12-31
- Completion
- 2004-10-31
More Related Trials
-
Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation
NCT00656552 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Medications for the Treatment of Dysthymic Disorder and Double Depression
NCT00234312 ·Status: COMPLETED ·Phase: PHASE4
-
Lexapro in the Treatment of Patients With Postpartum Depression
NCT00277108 ·Status: COMPLETED ·Phase: NA
-
Escitalopram in Adult Patients With Major Depressive Disorder
NCT00668525 ·Status: COMPLETED ·Phase: PHASE3
-
Lexapro for the Treatment of Traumatic Brain Injury (TBI) Depression & Other Psychiatric Conditions
NCT01368432 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder
NCT00107120 ·Status: COMPLETED ·Phase: PHASE3
-
Lexapro®'s Efficacy After Dose Escalation in Remission Study
NCT01594866 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe Depression
NCT01814085 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Escitalopram in Adult Patients With Major Depressive Disorder
NCT00108979 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder
NCT00109044 ·Status: COMPLETED ·Phase: PHASE3
-
Escitalopram (Lexapro®) In Patients With Major Depression With Atypical Features
NCT00610506 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Escitalopram Doses up to 50mg in Treatment of MDD
NCT00785434 ·Status: COMPLETED ·Phase: PHASE4
-
Escitalopram Treatment of Night Eating Syndrome
NCT00636649 ·Status: COMPLETED ·Phase: NA
-
Tolerability and Efficacy of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder (OCD)
NCT00305500 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms
NCT01814098 ·Status: COMPLETED ·Phase: PHASE4
-
Brain Imaging and Treatment Studies of the Night Eating Syndrome
NCT01401595 ·Status: COMPLETED ·Phase: PHASE3
-
Drug Therapy for Generalized Anxiety Disorder Among the Elderly
NCT00105586 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder
NCT00252330 ·Status: COMPLETED ·Phase: PHASE3
-
A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for Suicide
NCT02133001 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Escitalopram for Depression in Patients With Diabetes
NCT00650897 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder
NCT01198795 ·Status: COMPLETED ·Phase: PHASE4
-
Galantamine Augmentation of Escitalopram for Treatment of Depression
NCT00423969 ·Status: TERMINATED ·Phase: PHASE4
-
Biomarkers of Antidepressant Response and Suicidal Events in Depressed Youth
NCT03547219 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety Symptom
NCT01870843 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Escitalopram on the Sleep EEG Power in Patients With Major Depressive Disorder
NCT04013464 ·Status: COMPLETED ·Phase: NA